ustekinumab (Stelara®) is accepted for use within NHSScotland.

It has been approved for treatment of adult patients with moderately/severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies.


Scottish Medicines Consortium